Supplement Trial Registration

Written by the Health Supplements Singapore editorial team · Last updated: 4 August 2026

Supplement trial registration is a public record of what researchers planned to study, but it is not proof that a supplement works. This Singapore guide is general education, not medical advice: it shows how to compare registration timing, study status, participants, interventions, and outcomes with a later paper or product claim.

What a trial registration can show

The WHO Trial Registration Data Set specifies 24 items for a fully registered trial. They include the registry identifier, registration date, first-enrolment date, sponsor, study design, target sample size, recruitment status, interventions, eligibility criteria, and primary and secondary outcomes.

This planned record gives a reader a reference point. The ICMJE trial-registration guidance explains that prospective registration helps address selective publication and selective reporting. It recommends registration at or before the first participant's consent for enrolment.

A registry record does not certify a product, approve a claim, or replace the paper. Read it with the full publication and evidence behind the exact claim.

Start with registration timing

Compare the registry's registration date with its first-enrolment date. If registration came first, record it as prospective. If it came later, record it as retrospective or unclear, depending on the dates shown. ICMJE notes that registration at manuscript submission does not serve the purposes of prospective registration.

Timing is a transparency signal, not a verdict on the result. A late registration does not by itself prove that outcomes were changed, and an early registration does not guarantee that methods were followed. When a registry offers record versions, use the earliest available version to see what was entered before results were known.

Build a planned-versus-published record

This original comparison record was assembled from the verified WHO, ICMJE, and ClinicalTrials.gov protocol definitions, source-checked on 4 August 2026.

ClinicalTrials.gov defines a primary outcome as the measure of greatest importance specified in the protocol and asks for its title, description, and time frame. A result measured at eight weeks is not the same planned outcome as the same measure at six months.

Interpret differences cautiously

Not every difference is a problem. Recruitment can end below target, a measurement can be refined, or a paper can focus on a prespecified secondary analysis. The responsible reading step is to identify the difference and look for an explanation in the registry, protocol, paper, supplement, or correction.

Use neutral labels: matched, explained change, unexplained change, not reported, or unclear. Do not turn an unexplained difference into an accusation. Also do not treat a matching registry as evidence that a health claim is established.

For Singapore-facing claims, HSA's health-supplement claims guidance says evidence should be good quality and relevant to the claim. It also says sellers should not misuse or exaggerate research results or use scientific data the public cannot verify. Trial registration helps with transparency, while relevance and study quality still need separate checks.

Use a seven-step registry check

This original reading sequence was compiled from the same four live sources on 4 August 2026.

1. Find the registry number in the full paper, abstract, supplementary file, or protocol.
2. Open the public registry record and confirm that the title, intervention, and sponsor identify the same study.
3. Compare the registration date with the first-enrolment date.
4. Use the earliest available record version to capture the planned primary outcome and time frame.
5. Compare participants, intervention, comparator, sample size, and study status with the paper.
6. Record every outcome difference with a neutral label and any explanation the authors provide.
7. Check study match, funding disclosures, and wider independent evidence before weighing a product claim.

Keep the registry URL, paper link, version or access date, and notes together. This makes the check repeatable without inventing a score.

Questions people ask

Does a registered trial prove a supplement claim? No. Registration records planned information and improves transparency. It does not establish efficacy, safety, product equivalence, or personal suitability.

What if the paper has no trial number? Search cautiously by title, sponsor, intervention, investigators, and dates. If you cannot establish a match, label the registration as not found rather than assuming the trial was unregistered.

Is a changed primary outcome always misconduct? No. A change may have a documented reason. Record what changed, when it changed, and whether the paper or registry explains it; do not infer intent from the difference alone.

Can I compare a registry entry with a product advertisement? Yes, as a transparency check. First confirm that the cited study used the same ingredient or finished product, amount, participants, duration, and outcome. Avoid extending a study beyond what it actually tested.

This article is general educational information about health supplements in Singapore. It is not medical advice, diagnosis, treatment, or a compliance decision. For personal guidance—especially if you take medication, are pregnant, have a health condition, or are considering a high-dose product—speak with a doctor or pharmacist.

Related reading on this site: Supplement study match check · Supplement research funding · Supplement claims and evidence · Ingredient context

Sources

• HSA — Health supplement claims
• WHO — Trial Registration Data Set
• ICMJE — Clinical trial registration
• ClinicalTrials.gov — Protocol registration data element definitions